Biotechnology and Pharmaceuticals

August 12, 2016

Companies covered: Bayer AG (ADR) (OTCMKTS:BAYRY), Axovant Sciences Ltd (NYSE:AXON), AveXis Inc (NASDAQ:AVXS), uniQure N.V. (NASDAQ:QURE), Spark Therapeutics, Inc. (NASDAQ:ONCE), Ophthotech Corporation (NASDAQ:OPHT), Valeant Pharmaceuticals International, Inc. (NYSE:VRX), Novartis AG (NYSE:NVS), The Medicines Company (NASDAQ:MDCO), GlaxoSmithKline PLC (NYSE:GSK), Astrazeneca PLC (NYSE:AZN), Novo Nordisk A/S (NYSE:NVO), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Sanofi (NYSE:SNY), Pfizer, Inc. (NYSE:PFE), Regenxbio Inc (NASDAQ:RGNX), Endo International plc (NASDAQ:ENDP), Cipher Pharmaceuticals Inc. (NASDAQ:CPHR), NUVO PHARMACEUTICA COM NPV (OTCMKTS:NRIFF), Horizon Pharma plc (NASDAQ:HZNP), Retrophin, Inc. (NASDAQ:RTRX), Cempra, Inc. (NASDAQ:CEMP), Omeros Corporation (NASDAQ:OMER), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), T2 Biosystems, Inc. (NASDAQ:TTOO), Kadmon Holdings Inc (NYSE:KDMN), American International Group, Inc. (NYSE:AIG), Amgen Inc. (NASDAQ:AMGN), Biogen Idec Inc. (NASDAQ:BIIB), Celgene Corporation (NASDAQ:CELG), Sophiris Bio, Inc. (NASDAQ:SPHS), Mateon Therapeutics, Inc. (NASDAQ:MATN), PharmaCyte Biotech, Inc. (OTCMKTS:PMCB), Biostage, Inc. (NASDAQ:BSTG), Ignyta, Inc. (NASDAQ:RXDX), Asterias Biotherapeutics, Inc. (AMEX:AST), Hemispherx Biopharma, Inc. (NYSEMKT:HEB), pSivida Corp. (NASDAQ:PSDV), Aytu BioScience, Inc. (OTCMKTS:AYTU), Apricus Biosciences, Inc (NASDAQ:APRI)

Buy ($175)

Medical Devices

July 29, 2016

Companies covered: Mazor Robotics Ltd. (NASDAQ:MZOR), Nuvectra Corporation (NASDAQ:NVTR), Miramar Labs, Inc. (OTCMKTS:MRLB), Myriad Genetics, Inc. (NASDAQ:MYGN), TESARO, Inc. (NASDAQ:TSRO), Thermo Fisher Scientific Inc (NYSE:TMO), Waters Corporation (NYSE:WAT), CEPHEID (NASDAQ:CPHD), Boston Scientific Corporation (NYSE:BSX), Baxter International Inc. (NYSE:BAX), Medtronic, Inc. (NYSE:MDT), Intuitive Surgical, Inc. (NASDAQ:ISRG), Covidien Ltd. (NYSE:COV), Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), C.R. Bard, Inc. (NYSE:BCR), Illumina, Inc. (NASDAQ:ILMN), Cerner Corporation (NASDAQ:CERN), Edwards Lifesciences Corporation (NYSE:EW), St. Jude Medical, Inc. (NYSE:STJ), Hill-Rom Holdings Inc (NYSE:HRC), Cooper Companies, Inc. (The) (NYSE:COO), Teleflex Incorporated (NYSE:TFX)

Buy ($175)

Biotechnology and Pharmaceuticals

January 15, 2016

Companies covered: Gilead Sciences, Inc. (NASDAQ:GILD), Intra-Cellular Therapies Inc. (NASDAQ:ITCI), Cempra, Inc. (NASDAQ:CEMP), Achaogen, Inc. (NASDAQ:AKAO), Wave Life Sciences Ltd (NASDAQ:WVE), Intrexon Corporation (NYSE:XON), Johnson & Johnson (NYSE:JNJ), Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA), ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Fibrocell Science Inc (NASDAQ:FCSC), Synthetic Biologics, Inc (NYSEMKT:SYN), Juno Therapeutics, Inc. (NASDAQ:JUNO), Kite Pharma, Inc. (NASDAQ:KITE), Lightlake Therapeutics (OTCMKTS:LLTP), Cynapsus Therapeutics Inc (NASDAQ:CYNA), Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), Bio-Path Holdings, Inc. (NASDAQ:BPTH)

Buy ($175)

Pets & Vets

November 27, 2015

Companies covered: Zoetis Inc. (NYSE:ZTS), IDEXX Laboratories, Inc. (NASDAQ:IDXX), ABAXIS, Inc. (NASDAQ:ABAX), Henry Schein, Inc. (NASDAQ:HSIC), Patterson Companies, Inc. (NASDAQ:PDCO), AmerisourceBergen Corporation (Holding Co) (NYSE:ABC), VCA Inc. (NASDAQ:WOOF), PetMed Express, Inc. (NASDAQ:PETS), Aratana Therapeutics, Inc. (NASDAQ:PETX), Nexvet Biopharma plc (NASDAQ:NVET), Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), Yamaha Motor Co., Ltd. (TYO:7272), Jaguar Animal Health Inc (NASDAQ:JAGX), Phibro Animal Health Corporation (NASDAQ:PAHC), Kindred Biosciences, Inc. (NASDAQ:KIN), Trupanion, Inc. (NYSE:TRUP), Virbac SA (EPA:VIRP), Vetoquinol SA (EPA:VETO), Blue Buffalo Pet Products Inc (NASDAQ:BUFF), Freshpet, Inc. (NASDAQ:FRPT), Sanofi (NYSE:SNY), Merck & Company, Inc. (NYSE:MRK), Where Food Comes From, Inc. (OTCMKTS:WFCF), Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI), Eli Lilly and Company (NYSE:LLY), Novartis AG (NYSE:NVS), Cardinal Health, Inc. (NYSE:CAH), McKesson Corporation (NYSE:MCK), Pfizer, Inc. (NYSE:PFE), CVS Health Corporation (NYSE:CVS), Intersections, Inc. (NASDAQ:INTX)

Buy ($175)

Medical Research, Diagnostic Substances & Life Science Tools

October 23, 2015

Companies covered: Abbott Laboratories (NYSE:ABT), Illumina, Inc. (NASDAQ:ILMN), Alere Inc. (NYSE:ALR), Agilent Technologies, Inc. (NYSE:A), Bruker Corporation (NASDAQ:BRKR), Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corporation (NYSE:DHR), NanoString Technologies, Inc. (NASDAQ:NSTG), Genomic Health, Inc. (NASDAQ:GHDX), Stryker Corporation (NYSE:SYK), Teleflex Incorporated (NYSE:TFX), Zimmer Holdings, Inc. (NYSE:ZMH), Smith & Nephew SNATS, Inc. (NYSE:SNN), NuVasive, Inc. (NASDAQ:NUVA), Globus Medical, Inc. (NYSE:GMED), Accuray Incorporated (NASDAQ:ARAY), Medtronic, Inc. (NYSE:MDT), Varian Medical Systems, Inc. (NYSE:VAR), LeMaitre Vascular, Inc. (NASDAQ:LMAT), MiMedx Group, Inc (NASDAQ:MDXG), Johnson & Johnson (NYSE:JNJ), EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), Soligenix, Inc. (OTCBB:SNGX), Protea Biosciences Group, Inc. (OTCBB:PRGB), AmpliPhi Biosciences Corporation (NYSEMKT:APHB), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP), CombiMatrix Corporation (NASDAQ:CBMX), DBV Technologies S.A. (NASDAQ:DBVT), Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), United Cannabis Corporation (OTCBB:CNAB)

Buy ($175)

Pin It on Pinterest